Drugs that contain Albuterol Sulfate

1. Drug name - PROAIR DIGIHALER

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7540282 TEVA BRANDED PHARM Reservoir pressure system for medicament inhaler May, 2023

(6 months from now)

US10765820 TEVA BRANDED PHARM Dry powder inhalation apparatus May, 2025

(2 years from now)

US9463288 TEVA BRANDED PHARM Dry powder inhalation apparatus May, 2025

(2 years from now)

US8651103 TEVA BRANDED PHARM Dry powder inhalation apparatus Mar, 2028

(5 years from now)

US10124131 TEVA BRANDED PHARM Dose counter for inhaler having an anti-reverse rotation actuator May, 2031

(8 years from now)

US10022510 TEVA BRANDED PHARM Dose counters for inhalers, inhalers and methods of assembly thereof May, 2031

(8 years from now)

US9731087 TEVA BRANDED PHARM Dose counter for inhaler having a bore and shaft arrangement May, 2031

(8 years from now)

US9216260 TEVA BRANDED PHARM Dose counters for inhalers, inhalers and methods of assembly thereof Jun, 2031

(8 years from now)

US10561808 TEVA BRANDED PHARM Dose counter for inhaler having an anti-reverse rotation actuator Jan, 2032

(9 years from now)

US8978966 TEVA BRANDED PHARM Dose counters for inhalers, inhalers and methods of assembly thereof Jan, 2032

(9 years from now)

US9782550 TEVA BRANDED PHARM Compliance monitoring module for a breath-actuated inhaler Aug, 2035

(12 years from now)

US9782551 TEVA BRANDED PHARM Compliance monitoring module for a breath-actuated inhaler Aug, 2035

(12 years from now)

US10918816 TEVA BRANDED PHARM Compliance monitoring module for a breath-actuated inhaler Dec, 2035

(13 years from now)

US10569034 TEVA BRANDED PHARM Compliance monitoring module for a breath-actuated inhaler Aug, 2036

(13 years from now)

US11000653 TEVA BRANDED PHARM Inhaler Dec, 2038

(16 years from now)

US11173259 TEVA BRANDED PHARM Drug delivery device with electronics and power management Jul, 2040

(17 years from now)

Treatment: NA

Dosage: POWDER, METERED;INHALATION

More Information on Dosage
Strength Dosage Availability
EQ 0.09MG BASE/INH POWDER, METERED;INHALATION Prescription

2. Drug name - PROAIR HFA

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7105152 TEVA BRANDED PHARM Suspension aerosol formulations Sep, 2023

(11 months from now)

US8132712 TEVA BRANDED PHARM Metered-dose inhaler Sep, 2028

(5 years from now)

US9463289 TEVA BRANDED PHARM Dose counters for inhalers, inhalers and methods of assembly thereof May, 2031

(8 years from now)

US10086156 TEVA BRANDED PHARM Dose counter for inhaler and method for counting doses May, 2031

(8 years from now)

US10695512 TEVA BRANDED PHARM Dose counter for inhaler having an anti-reverse rotation actuator May, 2031

(8 years from now)

US10022509 TEVA BRANDED PHARM Dose counter for inhaler having a bore and shaft arrangement May, 2031

(8 years from now)

US9808587 TEVA BRANDED PHARM Dose counter for inhaler having an anti-reverse rotation actuator May, 2031

(8 years from now)

US10022510 TEVA BRANDED PHARM Dose counters for inhalers, inhalers and methods of assembly thereof May, 2031

(8 years from now)

US10561808 TEVA BRANDED PHARM Dose counter for inhaler having an anti-reverse rotation actuator Jan, 2032

(9 years from now)

Treatment: NA

Dosage: AEROSOL, METERED;INHALATION

More Information on Dosage
Strength Dosage Availability
EQ 0.09MG BASE/INH AEROSOL, METERED;INHALATION Prescription

3. Drug name - VENTOLIN HFA

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7832351 GLAXOSMITHKLINE Actuation indicator for a dispensing device Jun, 2023

(8 months from now)

US7832351

(Pediatric)

GLAXOSMITHKLINE Actuation indicator for a dispensing device Dec, 2023

(1 year, 2 months from now)

US7500444 GLAXOSMITHKLINE Actuation indicator for a dispensing device Feb, 2026

(3 years from now)

US7500444

(Pediatric)

GLAXOSMITHKLINE Actuation indicator for a dispensing device Aug, 2026

(3 years from now)

Treatment: NA

Dosage: AEROSOL, METERED;INHALATION

More Information on Dosage
Strength Dosage Availability
EQ 0.09MG BASE/INH AEROSOL, METERED;INHALATION Prescription

availability in other generic markets.

Click on the highlighted region to filter.